Bright Minds Biosciences Inc.

DRUG · NASDAQ
Analyze with AI
$93.99+$8.32 (+9.71%)
At close:Dec 16, 2025, 9:00 PM UTC
$93.81−$0.18 (−0.19%)
After hours:Dec 17, 2025, 12:58 AM UTC
P/E TTM-104.77
P/B TTM18.03
P/S TTM0
Dividend Yield0%
EPS-$0.99
Beta-0.529
Valuation
PEG Ratio0.70
FCF Yield-0.84%
EV / EBITDA-98.28
Quality
ROIC-19.11%
Gross Margin0.00%
Cash Conv. Ratio0.88
Growth
Revenue 3Y CAGR
FCF Growth73.66%
Safety
Net Debt / EBITDA5.70
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-4,864.67

Bright Minds Biosciences Inc. (DRUG) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Bright Minds Biosciences Inc. (DRUG) stock price today?

As of Dec 16, 2025, 9:00 PM UTC, Bright Minds Biosciences Inc. (DRUG) stock is trading at $93.99. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date DRUG stock quotes for informed trading decisions.

What is Bright Minds Biosciences Inc.'s market capitalization?

Bright Minds Biosciences Inc. (DRUG) has a market capitalization of approximately $665.9M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Bright Minds Biosciences Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the DRUG stock price changes.

What is the 52-week range for Bright Minds Biosciences Inc. stock?

Bright Minds Biosciences Inc. (DRUG) stock has traded in a 52-week range of $23.18 — $97.50. The 52-week range shows the highest and lowest prices at which DRUG traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Bright Minds Biosciences Inc. stock price to this range provides context for recent price action.

How much trading volume does Bright Minds Biosciences Inc. stock have?

Bright Minds Biosciences Inc. (DRUG) stock recently traded approximately 350.9K shares. Trading volume indicates market liquidity and investor interest in DRUG. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Bright Minds Biosciences Inc. stock.

Does Bright Minds Biosciences Inc. pay dividends to shareholders?

Yes, Bright Minds Biosciences Inc. (DRUG) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Bright Minds Biosciences Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Bright Minds Biosciences Inc.'s intraday price range?

Today, Bright Minds Biosciences Inc. (DRUG) stock has traded in a range of $84.81 — $97.75. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring DRUG's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Bright Minds Biosciences Inc. stock data?

AlphaPilot sources real-time DRUG stock quotes, fundamental financial data, and historical price charts for Bright Minds Biosciences Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Bright Minds Biosciences Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of DRUG stock performance.